Back to News
Market Impact: 0.55

Intel's turnaround under CEO Lip-Bu Tan gains steam with another strong quarter

Artificial IntelligenceCorporate EarningsCorporate Guidance & OutlookTechnology & InnovationCapital Returns (Dividends / Buybacks)Banking & Liquidity
Intel's turnaround under CEO Lip-Bu Tan gains steam with another strong quarter

Intel reported Q2 revenue of $16.1B (+25% YoY), beating the $14.42B consensus, and flipped to Non-GAAP EPS of $0.42 (vs -$0.10 a year ago) versus the $0.21 estimate. The company exceeded its own revenue guidance by $1.8B and raised/expanded its outlook with Q3 revenue expected at $15.8B–$16.8B (midpoint $16.3B vs $15.1B consensus) and Non-GAAP EPS forecast of $0.38 (vs $0.27 consensus). Intel also guided capex to >$20B in 2026 (about $3B higher than prior expectations), and shares rose ~4% after hours to around $104 following the results.

Analysis

This is a credibility re-rating story more than a pure demand story. The market is likely to reward INTC for proving it can turn supply tightness in CPUs and packaging into pricing power, but the next leg depends on whether that translates into durable share gains versus AMD rather than a one-quarter squeeze. In the near term, the beat/raise supports multiple expansion; over 6-12 months, the stock becomes much more sensitive to free-cash-flow math as capex ramps.

The foundry angle is the bigger second-order issue, but it is still mostly option value until external bookings show up. A higher 2026-27 capex path can improve strategic positioning while simultaneously depressing equity returns through heavier depreciation and longer payback, so the street may be underestimating how much proof is needed before assigning meaningful foundry value. That makes the current move vulnerable if management keeps delivering operating beats but not customer wins.

Relative losers are subtler: AMD faces a near-term narrative challenge if Intel regains socket-level credibility in data center CPUs, while TSM is less threatened operationally but could see a small valuation overhang if U.S. hyperscalers lean harder into dual-sourcing and domestic redundancy. The contrarian view is that the market may be overpricing a 2027-28 manufacturing payoff while underpricing execution risk and the possibility that AI workload mix shifts are less persistent than management suggests.